What Are SARMs?

Understanding SARMs

SARMs (Selective Androgen Receptor Modulators) are a class of therapeutic compounds that have similar properties to anabolic agents but with significantly reduced androgenic (producing male characteristics) properties. Unlike traditional anabolic steroids, SARMs selectively bind to androgen receptors in specific tissues — primarily muscle and bone — while exhibiting minimal activity in other tissues such as the prostate and sebaceous glands.

This tissue selectivity is what makes SARMs particularly valuable in research. They were originally developed in the late 1990s to address conditions such as muscle wasting, osteoporosis, and hypogonadism, where the anabolic effects of androgens are desired without the broad systemic side effects of traditional steroids.

How Do SARMs Work?

SARMs work by selectively binding to the androgen receptor (AR) in target tissues. When a SARM binds to the AR, it triggers a cascade of signalling that promotes anabolic activity — primarily protein synthesis and muscle growth — in muscle and bone tissue.

The key mechanism that distinguishes SARMs from anabolic steroids is their selective nature:

• Tissue-selective gene activation — SARMs activate different genes in different tissues, promoting anabolic effects in muscle while minimising androgenic effects elsewhere
• Conformational selectivity — different SARMs induce unique receptor conformations, leading to tissue-specific co-regulator recruitment
• Non-aromatisation — most SARMs do not convert to estrogen via aromatase, avoiding estrogen-related effects
• Non-5a-reduction — SARMs are generally not metabolised by 5a-reductase, reducing DHT-related effects on skin and hair

Key Research Compounds

Below are the primary SARMs and related research compounds currently available for scientific investigation:

Research Applications

SARMs are actively studied in numerous research contexts including:

• Muscle wasting diseases (sarcopenia, cachexia, muscular dystrophy)
• Osteoporosis and bone mineral density research
• Hypogonadism and androgen deficiency studies
• Breast cancer research (RAD-140 specifically)
• Metabolic syndrome and obesity research
• Age-related decline in physical function
• Post-surgical recovery and rehabilitation studies
• Male contraception research (S-23 specifically)

Quality Assurance

The integrity of any research study depends on the quality and purity of the compounds used. Critical quality indicators include:

• HPLC verification — confirms compound identity and purity (the accepted research threshold is 98%+)
• Mass spectrometry — confirms molecular weight and structural identity
• Batch-specific COA — Certificate of Analysis unique to each production batch ensures traceability
• Third-party testing — independent laboratory analysis provides objective quality verification
• GMP manufacturing — Good Manufacturing Practice compliance ensures consistent production quality